Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $140.98 -0.89%
Revenue Growth %: +30.8%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +30.8%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q2 EPS of ($0.18), in-line with the analyst estimate of ($0.18).
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- KB Home (KBH) PT Lowered to $50 at RBC Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
